Decoding the next SARS-CoV-2 variant
- PMID: 35597251
- PMCID: PMC9116896
- DOI: 10.1016/S2214-109X(22)00199-1
Decoding the next SARS-CoV-2 variant
Conflict of interest statement
JN reports grants from Wellcome Trust and Bill and Melinda Gates Foundation, and personal fees from Mylan, Cipla, Johnson and Johnson, Abbvie, and Virology Education. WDFV reports grants from USAID, Unitaid, the South African Medical Research Council, National Institutes of Health, Bill and Melinda Gates Foundation, and ViiV Healthcare; personal fees and non-financial support from ViiV and Gilead Sciences; and personal fees from Mylan, Merk, Adcock-Ingram, Aspen, Abbott, Roche, Johnson and Johnson, Sanofi, and Virology Education.
Comment on
-
Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.Lancet Glob Health. 2022 Jul;10(7):e961-e969. doi: 10.1016/S2214-109X(22)00114-0. Epub 2022 May 18. Lancet Glob Health. 2022. PMID: 35597249 Free PMC article.
References
-
- Callaway E. Beyond omicron: what's next for COVID's viral evolution. Nature. 2021 https://www.nature.com/articles/d41586-021-03619-8 - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
